Visceral leishmaniasis and HIV coinfection: time for concerted action.
作者信息
van Griensven Johan, Zijlstra Ed E, Hailu Asrat
机构信息
Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Rotterdam Centre for Tropical Medicine, Rotterdam, the Netherlands.
出版信息
PLoS Negl Trop Dis. 2014 Aug 28;8(8):e3023. doi: 10.1371/journal.pntd.0003023. eCollection 2014 Aug.
Abstract
摘要
相似文献
1
Visceral leishmaniasis and HIV coinfection: time for concerted action.内脏利什曼病与艾滋病毒合并感染：采取协同行动的时候了。
PLoS Negl Trop Dis. 2014 Aug 28;8(8):e3023. doi: 10.1371/journal.pntd.0003023. eCollection 2014 Aug.
2
Treatment Options for Visceral Leishmaniasis and HIV Coinfection.内脏利什曼病与艾滋病病毒合并感染的治疗选择
AIDS Rev. 2016 Jan-Mar;18(1):32-43.
3
Prevalence of Human Immunodeficiency Virus and associated factors among Visceral Leishmaniasis infected patients in Northwest Ethiopia: a facility based cross-sectional study.埃塞俄比亚西北部内脏利什曼病感染患者中人类免疫缺陷病毒的流行情况及相关因素：一项基于机构的横断面研究。
BMC Infect Dis. 2017 Feb 17;17(1):152. doi: 10.1186/s12879-017-2261-8.
4
HIV and visceral leishmaniasis coinfection in Bihar, India: an underrecognized and underdiagnosed threat against elimination.印度比哈尔邦的人类免疫缺陷病毒与内脏利什曼病合并感染：被忽视和漏诊的消除威胁。
Clin Infect Dis. 2014 Aug 15;59(4):552-5. doi: 10.1093/cid/ciu333. Epub 2014 May 10.
5
Leishmaniasis-HIV coinfection: current challenges.利什曼病与艾滋病病毒合并感染：当前挑战
HIV AIDS (Auckl). 2016 Oct 7;8:147-156. doi: 10.2147/HIV.S93789. eCollection 2016.
6
Perceived quality of life among Visceral Leishmaniasis and HIV coinfected migrant male-workers in Northwest Ethiopia: a qualitative study.埃塞俄比亚西北部内脏利什曼病和艾滋病毒合并感染的流动男性工人的生活质量认知：一项定性研究。
BMC Public Health. 2017 Feb 16;17(1):204. doi: 10.1186/s12889-017-4132-z.
7
HIV-1 protease inhibitors for treatment of visceral leishmaniasis in HIV-co-infected individuals.HIV-1 蛋白酶抑制剂治疗 HIV 合并内脏利什曼病个体。
Lancet Infect Dis. 2013 Mar;13(3):251-9. doi: 10.1016/S1473-3099(12)70348-1.
8
Atypical manifestations of visceral leishmaniasis in patients with HIV in north Ethiopia: a gap in guidelines for the management of opportunistic infections in resource poor settings.埃塞俄比亚北部 HIV 感染者内脏利什曼病的非典型表现：资源匮乏环境中机会性感染管理指南中的一个空白。
Lancet Infect Dis. 2015 Jan;15(1):122-9. doi: 10.1016/S1473-3099(14)70833-3. Epub 2014 Oct 7.
9
Epidemiological, clinical and laboratory aspects of human visceral leishmaniasis (HVL) associated with human immunodeficiency virus (HIV) coinfection: a systematic review.与人类免疫缺陷病毒（HIV）合并感染相关的人类内脏利什曼病（HVL）的流行病学、临床和实验室特征：一项系统综述
Parasitology. 2018 Dec;145(14):1801-1818. doi: 10.1017/S003118201800080X. Epub 2018 May 28.
10
Microbial translocation induces an intense proinflammatory response in patients with visceral leishmaniasis and HIV type 1 coinfection.微生物易位在并发内脏利什曼病和 HIV 1 型感染的患者中引发强烈的促炎反应。
J Infect Dis. 2013 Jul;208(1):57-66. doi: 10.1093/infdis/jit135. Epub 2013 Mar 28.
引用本文的文献
1
Endobronchial ultrasound transbronchial needle aspiration in the diagnosis of visceral leishmaniasis in a patient with human immunodeficiency virus infection.支气管内超声引导下经支气管针吸活检术在诊断一名人类免疫缺陷病毒感染患者内脏利什曼病中的应用
Lung India. 2025 May 1;42(3):266-267. doi: 10.4103/lungindia.lungindia_64_25. Epub 2025 Apr 29.
2
Insights to the HIV-associated visceral leishmaniasis clinical outcome: lessons learned about immune mediated disorders.对HIV相关内脏利什曼病临床结局的见解：关于免疫介导疾病的经验教训。
Front Immunol. 2025 Mar 12;16:1516176. doi: 10.3389/fimmu.2025.1516176. eCollection 2025.
3
T-cell activation and senescence in asymptomatic HIV/Leishmania infantum co-infection.无症状HIV/婴儿利什曼原虫合并感染中的T细胞活化与衰老
PLoS Negl Trop Dis. 2025 Mar 17;19(3):e0012848. doi: 10.1371/journal.pntd.0012848. eCollection 2025 Mar.
4
Advances in Cysteine Protease B Inhibitors for Leishmaniasis Treatment.用于治疗利什曼病的半胱氨酸蛋白酶B抑制剂的研究进展。
Curr Drug Targets. 2025;26(2):88-108. doi: 10.2174/0113894501324437240919064715.
5
Touching Base with Some Mediterranean Diseases of Interest from Paradigmatic Cases at the "Magna Graecia" University Unit of Infectious Diseases: A Didascalic Review.从“大希腊”大学传染病科典型病例探讨一些值得关注的地中海疾病：教学性综述
Diagnostics (Basel). 2023 Sep 1;13(17):2832. doi: 10.3390/diagnostics13172832.
6
Current leishmaniasis drug discovery.当前利什曼病药物研发
RSC Med Chem. 2022 Aug 26;13(9):1029-1043. doi: 10.1039/d1md00362c. eCollection 2022 Sep 21.
7
Precision Medicine in Control of Visceral Leishmaniasis Caused by .精准医学控制. 引起的内脏利什曼病
Front Cell Infect Microbiol. 2021 Nov 9;11:707619. doi: 10.3389/fcimb.2021.707619. eCollection 2021.
8
Frequency of Leishmania spp. infection among HIV-infected patients living in an urban area in Brazil: a cross-sectional study.巴西城区内感染 HIV 的患者中利什曼原虫属感染的频率：一项横断面研究。
BMC Infect Dis. 2020 Nov 25;20(1):885. doi: 10.1186/s12879-020-05622-2.
9
Need for sustainable approaches in antileishmanial drug discovery.抗利什曼原虫药物发现中可持续方法的必要性。
Parasitol Res. 2019 Oct;118(10):2743-2752. doi: 10.1007/s00436-019-06443-2. Epub 2019 Aug 31.
10
Miltefosine-Lopinavir Combination Therapy Against Infection: and Approaches.米替福新与洛匹那韦利托那韦联合治疗感染： 及 方法。
Front Cell Infect Microbiol. 2019 Jun 28;9:229. doi: 10.3389/fcimb.2019.00229. eCollection 2019.
本文引用的文献
1
A screen-and-treat strategy targeting visceral leishmaniasis in HIV-infected individuals in endemic East African countries: the way forward?在东非流行国家针对感染艾滋病毒个体的内脏利什曼病的筛查和治疗策略：未来之路？
PLoS Negl Trop Dis. 2014 Aug 7;8(8):e3011. doi: 10.1371/journal.pntd.0003011. eCollection 2014 Aug.
2
HIV and visceral leishmaniasis coinfection in Bihar, India: an underrecognized and underdiagnosed threat against elimination.印度比哈尔邦的人类免疫缺陷病毒与内脏利什曼病合并感染：被忽视和漏诊的消除威胁。
Clin Infect Dis. 2014 Aug 15;59(4):552-5. doi: 10.1093/cid/ciu333. Epub 2014 May 10.
3
"It's my blood": ethical complexities in the use, storage and export of biological samples: perspectives from South African research participants.“这是我的血液”：生物样本使用、储存及出口中的伦理复杂性：南非研究参与者的观点
BMC Med Ethics. 2014 Jan 22;15:4. doi: 10.1186/1472-6939-15-4.
4
Biobank research: time for discussion and debate.生物银行研究：是时候进行讨论和辩论了。
S Afr Med J. 2013 Mar 1;103(4):225-7. doi: 10.7196/samj.6813.
5
Microbial translocation induces an intense proinflammatory response in patients with visceral leishmaniasis and HIV type 1 coinfection.微生物易位在并发内脏利什曼病和 HIV 1 型感染的患者中引发强烈的促炎反应。
J Infect Dis. 2013 Jul;208(1):57-66. doi: 10.1093/infdis/jit135. Epub 2013 Mar 28.
6
Biobanking past, present and future: responsibilities and benefits.生物库的过去、现在和未来：责任与利益。
AIDS. 2013 Jan 28;27(3):303-12. doi: 10.1097/QAD.0b013e32835c1244.
7
The Human African trypanosomiasis specimen biobank: a necessary tool to support research of new diagnostics.人类非洲锥虫病样本生物库：支持新型诊断研究的必要工具。
PLoS Negl Trop Dis. 2012 Jun;6(6):e1571. doi: 10.1371/journal.pntd.0001571. Epub 2012 Jun 26.
8
Leishmaniasis worldwide and global estimates of its incidence.全球利什曼病及其发病率的全球估计。
PLoS One. 2012;7(5):e35671. doi: 10.1371/journal.pone.0035671. Epub 2012 May 31.
9
The diagnostic accuracy of serologic and molecular methods for detecting visceral leishmaniasis in HIV infected patients: meta-analysis.血清学和分子方法检测 HIV 感染患者内脏利什曼病的诊断准确性：荟萃分析。
PLoS Negl Trop Dis. 2012;6(5):e1665. doi: 10.1371/journal.pntd.0001665. Epub 2012 May 29.
10
Visceral leishmaniasis.内脏利什曼病。
Infect Dis Clin North Am. 2012 Jun;26(2):309-22. doi: 10.1016/j.idc.2012.03.005. Epub 2012 Apr 24.
Zotero 插件